Vascular endothelial growth factor in pulmonary hypertension

Annals of the New York Academy of Sciences

Volumn 796, Issue , 1996, Pages 186-193

  Voelkel, Norbert F ^a   Hoeper, Marius ^a   Maloney, James ^a   Tuder, Rubin M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITROPRUSSIDE SODIUM; SURAMIN; VASCULOTROPIN;

ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; ISOLATED LUNG; MALE; MONOCYTE; NONHUMAN; NORTHERN BLOTTING; PULMONARY HYPERTENSION; RAT;

ANIMALIA;

EID: 0029833777     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb32580.x     Document Type: Conference Paper

References (27)

1. REEVES, J. T. & N. F. VOELKEL. 1989. Mechanisms of Chronic Pulmonary Hypertension: Basic Considerations, Chap. 3, C. A. Wagenvoort & H. Denolin, Eds. Elsevier. Amsterdam.
2. WAGENVOORT, C. A. & N. WAGENVOORT. 1979. Pulmonary vascular bed: Normal anatomy and responses to disease. In Pumonary Vascular Disease, K. M. Moser, Ed. Lung Biology in Health and Disease, Vol. 14. Marcel Dekker. New York.
3. TUDER, R. M., B. GROVES, D. B. BADESCH & N. F. VOELKEL. 1994. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am. J. Pathol. 144: 275-285.
4. RABINOVITCH, M. 1989. Mechanisms of pulmonary hypertension in chronic high flow states. Pul. Phys. Pathol., E. K. Weir & J. T. Reeves, Eds.: 469-511.
5. HEATH, D. & D. WILLIAMS. 1991. Pulmonary vascular remodelling in a high-altitude Aymara Indian. Int. J. Biometeorol. 35: 204-207.
6. WILKINSON, M., C. A. LANGHORNE, D. HEATH, G. R. BARER & P. HOWARD. 1988. A pathophysiological study of 10 cases of hypoxic cor pulmonale. Quart. J. Med. 66: 65-85.
7. MONACCI, W. T., M. J. MERRILL & E. H. OLDFIELD. 1993. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am. J. Physiol. 264: C994-C1002.
8. SENGER, D. R., S. J. GALLI, A. M. DVORAK, C. A. PERRUZZI, V. S. HARVEY & H. F. DVORAK. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985.
9. BERSE, B. L., F. BROWN, L. VAN DE WATER, H. F. DVORAK & D. R. SENGER. 1992. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumors. Mol. Biol. Cell 3: 211-220.
10. TUDER, R. M., D. B. BADESCH, B. GROVES, D. A. LYNCH & N. F. VOELKEL. 1994. Vascular endothelial permeability/growth factor expression in plexogenic pulmonary hypertension. J. Cell. Biochem. Suppl. 18A: 330.
11. SHWEIKI, D. A., ITIN, D. SOFFER & E. KESHET. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (London) 359: 843-845.
12. TUDER, R. M., B. E. FLOOK & N. F. VOELKEL. 1995. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. J. Clin. Invest. 95: 1798-1807.
13. SINZINGER, H. 1987. In Prostacyclin and Its Stable Analogue Iloprost, R. S. Gryglewski and G. Stock, Eds.: 293-294. Springer-Verlag. Berlin.
14. HOEPER, M. M., T. O. BATES, M. HORAN, N. F. VOELKEL & R. M. TUDER. The prostacyclin-analogue iloprost induces vascular endothelial growth factor in a human monocytic cell line and in rat lungs via a cAMP-dependnet mechanism. Am. J. Pathol. Under review.
15. CHOMCYNSKI, P. & N. SACCHI. 1987. Single-step method of RNA isolation by acid guanidinium-thiocyanate phenol chloroform extraction. Anal. Biochem. 162: 156-159.
16. TERMAN, B. I., M. DOUGHER-VERMAZEN, M. E. CARRION, D. DIMITROV, D. C. ARMELLINO, D. GOSPODAROWICZ & P. BOHLEN. 1992. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187: 1579-1586.
17. QUINN, T. P., K. G. PETERS, C. DEVRIES, N. FERRARA & L. T. WILLIAMS. 1993. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. U.S.A. 90: 7533-7537.
18. JAKEMAN, L., B. J. WINER, G. L. BENNETT, C. A. ALTAR & N. FERRARA. 1992. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J. Clin. Invest. 89: 244-253.
19. SHIBUYA, M., S. YAMAGUCHI, A. YAMANE, T. IKEDA, A. TOJO, H. MATSUSHIME & M. SATO. 1990. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5: 519-524.
20. WALTENBERGER, J., L. CLAESSON-WELSH, A. SIEGBAHN & D. H. HELDIN. 1994. Functional comparison of KDR and Fit receptors for the vascular endothelial growth factor. J. Cell Ciochem. Suppl. 18A: 322.
21. MUSTONEN, T. & K. ALITALO. 1995. Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell Biol. 129: 895-898.
22. JONES, D. K., T. W. HIGENBOTTAM & J. WALLWORK. 1987. Treatment of primary pulmonary hypertension with intravenous epoprostenol (porstacyclin). Br. Heart J. 57: 270-278.
23. RUBIN, L. J., J. MENDOZA & M. HOOD. 1990. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): Results of a randomized trial. Ann. Intern. Med. 112: 485-491.
24. HOSANG, M. 1985. Suramin binds to platelet-derived growth factor and inhibits its biological activity. J. Cell. Biochem. 29: 265-273.
25. PESENTI, E., F. SOLA, N. MONGELLI, M. GRANDI & F. SPREAFICO. 1992. Suramin prevents neovascularization and tumor growth through blocking of basic fibroblast growth factor activity. Br. J. Cancer 66: 367-372.
26. STAVRI, G. T., Y. HONG, I. C. ZACHARY, G. BREIER & P. A. BASKERVILLE, S. YLAHERTTUALA, W. RISAU, J. F. MARTIN & J. D. ERUSALIMSKY. 1995. Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS Lett. 358: 311-315.
27. 1 in osteoblasts. J. Clin. Invest. 93: 2490-2496.